Keywords: Savient Pharma, CEO, Eli Lilly

President of Lilly Oncology quits to take up CEO post at Savient

Article | 26 January 2011

Print This

US drug major Eli Lilly (NYSE: LLY) announced yesterday that John Johnson, senior vice president and president of Lilly Oncology, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in